AUTOIMMUNITY- III. Autoimmunity Part-III l At the end of the session the student should be able to: l a. Describe the pathogenesis of important autoimmune.

Slides:



Advertisements
Similar presentations
RHEUMATOID ARTHRITIS MUHAMMAD ADEEL (BIOT 412) Human Diseases Presentation.
Advertisements

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
DR SANTOSH KUMAR ASSISTANT PROFESSOR MEDICINE UNTI 2.
Autoimmunity Quiz Emily Matthews Chris Lancaster
Immunology Stack Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant.
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Value of inflammatory markers Useful for diagnosis of inflammatory vs non inflammatory conditions Remember NON-SPECIFIC, increased in infection, inflammation,
“SLE: Fighting Self Sabotage” Feb Immunology in health and Disease Susan Manzi, MD, MPH Associate Professor of Medicine and Epidemiology Co-Director.
Chapter 18 Autoimmune Diseases 1. 1.Immunological homeostasis: To self Ag, our immune system is in tolerance and immune response won’t take place. Immune.
Systemic Lupus Erythematosus
Department of Pathology
Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.
Systemic Lupus Erythematosis. The Immune System Immunology Connection to Tissue Engineering Develop methods to selectively block immune response to engineered.
Lecture 22 Autoimmunity.
Image From collection/systemic_lupus_erythematosus_1_picture/pict ure.htm.
Rheumatoid Arthritis(RA)
Autoimmune Disease Rheumatoid Arthritis And Systemic Lupus Erythematosus 1.
Laboratory Tests in Rheumatology
PhD. student kefah F.Hasson 2014 Hypersensitivity Reactions type III.
Lecture 8 immunology Autoimmunity Dr. Dalia Galal.
Autoimmunity Immune system has evolved to discriminate between self and non-self or discriminate between safe and dangerous signalsImmune system has evolved.
Systemic Lupus Erythematosus and Rheumatoid arthritis 醫學一 B 王樂詠 B 許伊婷.
1 Dr. Amel Eassawi Dr. Abdelrahman Mustafa. HMIM 224 L3: AUTOTOLERANCE 2.
DR.A.Tahamoli Rudsari.  Rheumatoid arthritis (RA) is a chronic multisystem disease of unknown cause.  Although there are a variety of systemic manifestations,
AIM OF THIS PRESENTATION  Introduce the important components of the Autoimmune Diseases.  Demonstrate what happens when things go wrong & the body turns.
Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.
AUTOIMMUNITY. Self/Non-self Discrimination Autoimmunity is a problem of self/non-self discrimination.
Chapter 28 Autoimmune Disorders.
Autoimmunity and Type I Diabetes CCMD 793A: Fundamental Integrated SystemsFALL, 2006 James M. Sheil, Ph.D.
AUTOIMMUNITY-I,II, III PRACTICAL 4. l Case No 1 l A 25-year-old woman has had increasing malaise, a skin rash of her face exacerbated by sunlight exposure,
R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.
AUTOIMMUNITY. Autoimmunity Breaking of self tolerance Both B and T cells may be involved (however, most are antibody mediated)
Sarra Abdurrezag Esharik Systemic Lupus Erythematosus (SLE)
Autoimmune Diseases How Do the Immune Cells of the Body Know What to Attack and What Not To Attack ?
Chapter 15 Care of the Patient with an Immune Disorder Mosby, Inc. items and derived items copyright © 2003, 1999, 1995, 1991 Mosby, Inc.
RHEUMATOID ARTHRITIS (RA)
Mechanisms of Autoimmunity Immunology Unit Department of Pathology College of Medicine.
Pathology of thyroid 2 Dr: Salah Ahmed. Thyroiditis - inflammation of the thyroid gland, includes a group of disorders characterized by some form of thyroid.
AUTOIMMUNITY- I.
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
AUTOIMMUNITY- II Dr. Ashraf Abdelfatah Deyab Assistant Professor of Pathology Collage of Medicine, Majmaah University-
Autoimmunity and Autoimmune Disease
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
CATEGORY: IMMUNE DYSFUNCTION Systemic Lupus Erythematosus (SLE) Angela Midgley, University of Liverpool, UK S YSTEMIC L UPUS E RYTHEMATOSUS © The copyright.
Immunopathology Dr. Maysem Lec.3.
4. Rheumatologic conditions
Rheumatic Diseases “Arthritis”
Department of Pathology
Systemic lupus erythematosus
Objective 17 Hypersensitivity
Autoimmunity & Autoimmune diseases Lecture-4
Systemic Lupus Erythematosus (SLE)
AUTOIMMUNITY AND AUTOIMMUNE DISEASE
Unit 3 Autoimmunity Part 1 Introduction
Autoimmune diseases Ch. 4 p (99 – 159) March 7 /2016 March
ILOs of the second lecture
Mechanisms of Autoimmunity Department of Pathology
Failures against ‘self’ (Principles of Autoimmunity)
Autoimmune Diseases Autoimmune Diseases Presented By Dr. Manal Yassin.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Immunological Tolerance and Autoimmune Diseases
AUTOIMMUNE DISEASES.
Quiz 3 review | September 21, 2016
Quiz 3 review | September 23, 2015
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
References Kuby Immunology 7th Edition 2013 Chapter 16 Pages Pages
Department of Pathology
Department of Pathology
Mechanisms of Autoimmunity Department of Pathology
Presentation transcript:

AUTOIMMUNITY- III

Autoimmunity Part-III l At the end of the session the student should be able to: l a. Describe the pathogenesis of important autoimmune disorders: l 1) SLE. l 2) Rheumatoid arthritis. l 3) Sjogren’s syndrome etc. l Suggested readings: Robbins basic pathology, 8th edition. Page:

Diagnostic criteria for autoimmune diseases l Three requirements should be met: l (1) Presence of an immune reaction specific for some self-antigen or self-tissue. l (2) Evidence that such a reaction is not secondary to tissue damage but is of primary pathogenic significance. l 3) Absence of another well-defined cause of the disease.

How to establish the Diagnosis l History: characteristic symptoms l Classical physical findings and signs l Imaging& Laboratory studies: »Radiological »General: UG, CBC, ↑ESR, ↑CRP, RF »Hormonal assay »? HLA »Renal and skin biopsy – H&E + IF »Auto-antibodies Screening (serology, IF)

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) l SLE- a multisystem disease of autoimmune origin, characterized by a vast array of autoantibodies, particularly antinuclear antibodies (ANAs). l SLE predominantly affects women. l SLE manifest in any age even early childhood l Clinical presentation: l complex of criteria approved by (American society of rheumatology), different presentation. Acute or insidious in its onset, chronic, remitting and relapsing. l febrile illness, injury to the skin, joints, kidney, and serosal membranes. other organ in the body,

SLE- Pathogenesis l The cause of SLE remains unknown. l SLE—both documented and postulated—are as varied and complex l The pathogenesis: l 1) Genetic factors. l 2) Immunological factors l 3) Environmental factors. l Outcoms l Antibodies against self-constituents (SM, Nuclei, Nucleoli, DNA)due to a failure of the mechanisms that maintain self-tolerance.

SLE- Pathogenesis 1) Genetic susceptibility. contributions from MHC and multiple non-MHC genes l Evidence support a genetic predisposition: l a) Family history- increased risk.1 st degree. l b) Monozygot twins – higher rate l c) Studies of HLA associations- HLA-DQ locus > produce Anti-sm, DNA, Phospholipid. l d) Inherited deficiencies of early complement components, such as C2, C4, or C1q.>> impair removal of circulating immune complexes& Tissue deposition+ loss of B tolerance.

SLE- Pathogenesis l 2) Immunological Factors: a) Defective elimination of self-reactive B cells b) Escape tolerance CD4+ helper T cells specific for nucleosomal antigens>production autoantibodies. c) Nuclear DNA and RNA contained in immune complexes may activate B lymphocytes. d) The role of cytokines (interferons-1, TNF), release as response to Viral infection lead to >> activate dendritic cells, B cells& promote T H 1 responses>production of autoantibodies.

SLE- Pathogenesis l 3) Environmental Factors: a) Exposure to ultraviolet (UV) light exacerbates SLE>> induce enhance inflammation, apoptosis & alter the DNA >> Immunogenic. a) Sex hormones> exert an important influence on the occurrence and manifestations of SLE. b) Drugs such as hydralazine, procainamide, and D- penicillamin > induce an SLE-like response.

Rheumatoid arthritis l RA- defined as autoimmune disease (multi- systemic, non-organ specific) with Articular & Extra-articular manifestations. l Articular lesion- chr. by Non-suppurative proliferative synovitis, which leads to destruction of articular cartilage >> Lead to progressive disabling arthritis. l Extra-articular manifestation may strongly resemble SLE or scleroderma- such as the skin, blood vessels, lungs, and heart. l Age: Usual onset in decades 4 and 5 l Sex: 3-5X more common in women than in men

Rheumatoid arthritis l Etio-Pathogenesis: l precise trigger which initiates destructive immune response is not known l Specificity of Pathogenic T Cells: Unknown antigen in joint synovium (type II collagen?); role of antibodies ? l 1- Genetic susceptibility l 2- Environmental arthritogen l 3- Immunological factor

Rheumatoid arthritis-Pathogenesis l 1- Genetic susceptibility: l Non-HLA gene (PTPN22)> Tyrosine activity>> regulate and control T cell responses. l HLA-DRB1 associated with increased incidence of the inflammatory synovitis. l 2- Environmental arthritogen (implicated not proven) Smoking& infection(EBV,Proteus, M.tuberculosis). l 3- Immunological factors: l 3- 80% of +VE To RA factors (antibodies against Fc portion of IgG). l Initiated by activation of T-helper cells which produce cytokines and activate B cells to produce antibodies.

Rheumatoid arthritis l Clinical course »symmetrical, polyarticular arthritis »weakness, fever, malaise may accompany joint symptoms »stiffness of joints in AM early, then progresses to claw-like deformities »severely crippling in years, life expectancy reduced 4-10 years. »Amyloidosis develops in 5%-10% of patients »Anemia of chronic disease present in late cases

 NORMAL Bi-Layered Synovium ↑ Destructive Rheumatoid Synovitis

Sjogren’s syndrome- SS l is a chronic Autoimmune disease chr. by Dry eyes (keratoconjunctivitis sicca) and Dry mouth (xerostomia) due to immune destruction of the lacrimal and salivary glands l Sicca syndrome - this phenomenon occurring as an isolated primary syndrome. l Extraglandular manifestations, such as cutaneous vasculitis,nephritis, etc… l Frequently associated with RA, some with SLE or other autoimmune processes.

Sjogren’s syndrome- SS l Etio-pathogenesis of SS - remains obscure l 1- Genetic- HLA gene: SS - associated with certain HLA alleles, HLA-DR3, HLA-B8,etc… l 2- Environmental factors : Viral infection of salivary glands “unclear relation”- e.g EPV HCV>> cells injury, death >> release self antigens>> B& T cell self activation. l The Primary target is ductal epithelial cells of exocrine glands, by chronic inflammatory infiltrates:CD4-T& B cells-plasma cells.

Sjogren’s syndrome-SS »Types of auto-antibodies : »75% of patient present with rheumatoid factor (an antibody reactive with self-IgG). » % Presented with ANA. » 90% most have Ab against two ribo- nucleoprotein antigens anti -SS-A (R0) (early) and anti-SS-B (La) antibodies. The outcome: Salivary gland destruction, inflammation, fibrosis>>dry eyes + dry mouth

Sjogren’s syndrome l Clinical course »primarily in women > »dry mouth, Nose-difficult swallowing solid diet, cracks, fissures, Lack of tears-Blurring vision, thick secretion »Salivary glands enlarged-50% parotid »EXTRANODAL manifestation: recurrent bronchitis, and pneumonitis, lung fibrosis, RA-synovitis » 1% develop lymphoma, 10% with pseudo- lymphomas »The combination of lacrimal & salivary gland inflammatory event called Mikulicz disease/ syndrome

Thanks